KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to -$26.1 million.

  • Resmed's Change in Inventory fell 44195.79% to -$26.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$9.2 million, marking a year-over-year increase of 4657.53%. This contributed to the annual value of $80.2 million for FY2025, which is 14655.26% up from last year.
  • Resmed's Change in Inventory amounted to -$26.1 million in Q4 2025, which was down 44195.79% from $14.7 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Change in Inventory registered a high of $147.1 million during Q3 2022, and its lowest value of -$86.2 million during Q1 2024.
  • Its 5-year average for Change in Inventory is $22.2 million, with a median of $14.4 million in 2021.
  • Its Change in Inventory has fluctuated over the past 5 years, first soared by 55794.65% in 2021, then plummeted by 49225.94% in 2024.
  • Quarter analysis of 5 years shows Resmed's Change in Inventory stood at $83.3 million in 2021, then rose by 3.3% to $86.0 million in 2022, then tumbled by 158.34% to -$50.2 million in 2023, then surged by 115.23% to $7.6 million in 2024, then crashed by 441.96% to -$26.1 million in 2025.
  • Its last three reported values are -$26.1 million in Q4 2025, $14.7 million for Q3 2025, and $32.1 million during Q2 2025.